Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kim A,Tran

第一单位： College of Pharmacy, Oregon State University at Oregon Health & Science University, Portland.

作者： Kim A,Tran ^[1] ; Curtis,Harrod ^[2] ; Dennis N,Bourdette ^[3] ; David M,Cohen ^[4] ; Atul A,Deodhar ^[5] ; Daniel M,Hartung ^[1]

作者单位： College of Pharmacy, Oregon State University at Oregon Health & Science University, Portland. ^[1] Center for Evidence-based Policy, Oregon Health & Science University, Portland. ^[2] Department of Neurology, Oregon Health & Science University, Portland. ^[3] Division of Nephrology and Hypertension, Department of Medicine, Oregon Health & Science University, Portland. ^[4] Division of Arthritis and Rheumatic Diseases, Department of Medicine, Oregon Health & Science University, Portland. ^[5]

主题词肾上腺皮质激素类(Adrenal Cortex Hormones);促肾上腺皮质激素(Adrenocorticotropic Hormone);关节炎, 类风湿(Arthritis, Rheumatoid);女(雌)性(Female);人类(Humans);男(雄)性(Male);多发性硬化(Multiple Sclerosis);肾病综合征(Nephrotic Syndrome);痉挛, 婴儿(Spasms, Infantile);美国(United States);美国食品和药物管理局(United States Food and Drug Administration)

DOI 10.1001/jamainternmed.2021.7171

PMID 34902005

发布时间 2022-05-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

JAMA internal medicine

2022年182卷2期

206-217页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.

JAMA internal medicine

相似文献

JAMA internal medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.

JAMA internal medicine

相似文献

JAMA internal medicine

相关期刊

检索历史清除